AIDA
Axin interactor, dorsalization-associated protein
Also known as: AIDA_HUMAN, C1orf80, FLJ12806
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96BJ3
- Gene
- AIDA
- Ensembl
- ENSG00000186063
- Chromosome
- 1
- Canonical length
- 306 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Microtubules,Cytokinetic bridge,Primary cilium,Basal body
OverviewNCBI Gene
Predicted to enable phosphatidylinositol binding activity. Acts upstream of or within negative regulation of JUN kinase activity. Predicted to be located in cytoplasm. Predicted to be active in membrane. [provided by Alliance of Genome Resources, Jul 2025]
Canonical amino-acid sequenceUniProt
306 residues, UniProt reviewed canonical sequence.
>Q96BJ3|AIDA
1 MSEVTRSLLQ RWGASFRRGA DFDSWGQLVE AIDEYQILAR HLQKEAQAQH NNSEFTEEQK
61 KTIGKIATCL ELRSAALQST QSQEEFKLED LKKLEPILKN ILTYNKEFPF DVQPVPLRRI
121 LAPGEEENLE FEEDEEEGGA GAGSPDSFPA RVPGTLLPRL PSEPGMTLLT IRIEKIGLKD
181 AGQCIDPYIT VSVKDLNGID LTPVQDTPVA SRKEDTYVHF NVDIELQKHV EKLTKGAAIF
241 FEFKHYKPKK RFTSTKCFAF MEMDEIKPGP IVIELYKKPT DFKRKKLQLL TKKPLYLHLH
301 QTLHKELocalizationUniProt · AlphaFold · HPA
Whether an antibody against AIDA can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.31
- Highest tissue expression
- 68 nTPM
Expression across tissuesHPA
Tissue
- adipose tissue: 68 nTPM
- epididymis: 53 nTPM
- smooth muscle: 51 nTPM
- blood vessel: 50 nTPM
- tonsil: 50 nTPM
- lymph node: 48 nTPM
Single-cell type
- microglia: 68 nCPM
- b-cells: 50 nCPM
- sertoli cells: 45 nCPM
- erythrocyte progenitors: 37 nCPM
- adipocytes: 33 nCPM
- alveolar cells type 2: 32 nCPM
Immune cell
- memory B-cell: 14 nTPM
- naive B-cell: 14 nTPM
- T-reg: 10 nTPM
- naive CD4 T-cell: 7.4 nTPM
- memory CD4 T-cell: 7.2 nTPM
- plasmacytoid DC: 7.2 nTPM
Brain region
- white matter: 75 nTPM
- medulla oblongata: 65 nTPM
- basal ganglia: 63 nTPM
- hypothalamus: 62 nTPM
- pons: 61 nTPM
- spinal cord: 55 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.88
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.96
- DepMap mean gene effect
- 0.03
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 9% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- dorsal/ventral pattern formation
- negative regulation of JNK cascade
- negative regulation of JUN kinase activity
- negative regulation of protein-containing complex assembly
- determination of ventral identity
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- C2 domain superfamily
- Axin interactor, dorsalization-associated protein, N-terminal
- Axin interactor dorsalization-associated protein, C-terminal
- Axin interactor, dorsalization-associated protein, N-terminal domain superfamily
- Aida N-terminus
- Axin interactor dorsalisation-associated protein, C-terminal
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of AIDA in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads AIDA as an antibody target. Whether an autoantibody or antibody against AIDA could matter depends on whether native AIDA is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
AIDA is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label AIDA as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...